Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Current Opinion in Rheumatology|July 14, 2020
Update on the treatment of nonsystemic juvenile idiopathic arthritis including treatment-to-target: is (drug-free) inactive disease already possible?Inge R Klein-Wieringa, Danielle M C Brinkman, Rebecca Ten Cate, et al.Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|January 5, 2024
An Uncommon Cause of Nocturnal Crying and Discomfort: A Case of a 15-month-old Girl With SpondylodiscitisLotje A Hoogervorst, Janne L Punski-Hoogervorst, Amoe Baktash, et al.The Pediatric Infectious Disease Journal|August 12, 2021
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Without Recurrence of Multisystem Inflammatory Syndrome in ChildrenEmilie P Buddingh, Ann C T M Vossen, Hildo J Lamb, et al.Cytotherapy|January 15, 2013
Mesenchymal stromal cells isolated from children with systemic juvenile idiopathic arthritis suppress innate and adaptive immune responsesFriso G J Calkoen, Danielle M C Brinkman, Carly Vervat, et al.Pediatric Blood & Cancer|April 9, 2009
Atypical varicella zoster infection associated with hemophagocytic lymphohistiocytosisJutte E van der Werff ten Bosch, Wouter J W Kollen, Lynne M Ball, et al.BMC Medical Ethics|December 22, 2018
Participation in a single-blinded pediatric therapeutic strategy study for juvenile idiopathic arthritis: are parents and patient-participants in equipoise?Petra C E Hissink Muller, Bahar Yildiz, Cornelia F Allaart, et al.RMD Open|March 17, 2023
Patterns of clinical joint inflammation in juvenile idiopathic arthritisSascha L Heckert, Petra C E Hissink-Muller, J Merlijn van den Berg, et al.Annals of the Rheumatic Diseases|October 13, 2018
Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trialPetra Hissink Muller, Danielle M C Brinkman, Dieneke Schonenberg-Meinema, et al.Rheumatology (Oxford, England)|February 10, 2022
Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal studyM Javad Wahadat, Dieneke Schonenberg-Meinema, Cornelia G van Helden-Meeuwsen, et al.Rheumatology (Oxford, England)|June 7, 2013
Treatment choices of paediatric rheumatologists for juvenile idiopathic arthritis: etanercept or adalimumab?Janneke Anink, Marieke H Otten, Simone L Gorter, et al.Pageof 1